Previous Close | 15.53 |
Open | 15.21 |
Bid | 16.02 x 500 |
Ask | 16.07 x 700 |
Day's Range | 15.12 - 16.09 |
52 Week Range | 10.87 - 83.60 |
Volume | |
Avg. Volume | 1,302,716 |
Market Cap | 1.725B |
Beta (5Y Monthly) | 0.43 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
NovoCure Limited (NASDAQ:NVCR) Q1 2024 Earnings Call Transcript May 2, 2024 NovoCure Limited beats earnings expectations. Reported EPS is $-0.36134, expectations were $-0.43. NVCR isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and thank you for standing by. […]
Comprehensive Analysis of NovoCure's First Quarter Financial Performance
NovoCure (NVCR) delivered earnings and revenue surprises of 16.28% and 5.30%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?